Forxiga® - Diabetes
10mg | Tablets
You have dispensed Forxiga® 10mg or Xigduo® 5mg to a patient or you have obtained this medicine from the pharmacy. The health care insurer does not yet reimburse this medication as monotherapy or for specific combination treatment. The producer of this medicine has therefore asked TBR Nederland to reimburse the costs of the Personal Contribution to the patient.
|Dose||Forxiga® 10mg and Xigduo® 5mg|
|Active ingredient||DAPAGLIFLOZINE and DAPAGLIFLOZINE WITH METFORMINE|
With immediate effect this scheme is applicable for all adults (18 years and older) with Diabetes Mellitus type 2 who are depend on Forxiga® 10mg or Xigduo® 5mg and fall outside de current reimbursement conditions*.
Contrary to the previous scheme, due to new conditions, a doctor's statement is no longer required.
* Forxiga® and Xigduo® are currently reimbursed in combination with metformine and/or a SU-derivative.
You can only submit invoices with an issue date from 1-7-2019. You cannot submit invoices with an issue date for 1-7-2019 at TBR Nederland.
Patients and pharamcists can claim online and will receive the reimbursement within 5 working days.
Patients can claim by post and will receive their reimbursement within 15 working days.
Please mail the Claim Form and attachments to:
1180 LA Amstelveen
Quickly check the maximum contribution you have to pay for your medicine